Principal Financial Group Inc. Sells 15,547 Shares of Chemed Co. (NYSE:CHE)

Principal Financial Group Inc. cut its stake in Chemed Co. (NYSE:CHEFree Report) by 30.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 34,867 shares of the company’s stock after selling 15,547 shares during the quarter. Principal Financial Group Inc.’s holdings in Chemed were worth $20,954,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. American National Bank & Trust purchased a new stake in shares of Chemed during the third quarter valued at approximately $61,000. GAMMA Investing LLC grew its stake in Chemed by 60.5% in the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock valued at $83,000 after purchasing an additional 52 shares during the period. Quarry LP increased its position in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares during the last quarter. Sound Income Strategies LLC bought a new stake in shares of Chemed during the 3rd quarter worth $201,000. Finally, Farther Finance Advisors LLC boosted its holdings in shares of Chemed by 2,314.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after buying an additional 324 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In other Chemed news, EVP Spencer S. Lee sold 732 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the sale, the executive vice president now owns 18,287 shares in the company, valued at $10,526,362.94. This trade represents a 3.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the transaction, the chief executive officer now owns 101,735 shares of the company’s stock, valued at $58,270,755.95. The trade was a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 3.32% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on CHE shares. Royal Bank of Canada decreased their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th.

Get Our Latest Analysis on Chemed

Chemed Stock Up 0.5 %

Shares of NYSE CHE opened at $519.87 on Thursday. The business has a 50-day simple moving average of $561.08 and a two-hundred day simple moving average of $563.73. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62. The company has a market cap of $7.82 billion, a P/E ratio of 26.27, a P/E/G ratio of 2.32 and a beta of 0.46.

Chemed (NYSE:CHEGet Free Report) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million during the quarter, compared to analysts’ expectations of $612.22 million. During the same quarter in the prior year, the company earned $5.32 earnings per share. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. Equities research analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were given a dividend of $0.50 per share. The ex-dividend date was Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.38%. Chemed’s payout ratio is presently 10.11%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Further Reading

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.